Literature DB >> 1900054

Binding of the specific ligand to Fc receptors on Trypanosoma cruzi increases the infective capacity of the parasite.

C Rodriguez de Cuna1, F Kierszenbaum, J J Wirth.   

Abstract

The infective capacity of Trypanosoma cruzi was significantly increased after treatment with monoclonal IgG1 antibodies, whether or not specific for the parasite; minimal or no change in infectivity was seen after treatment with IgG2a, IgG2b or IgG3 monoclonal antibodies. The stimulatory effect was evidenced by elevated numbers of trypanosomes invading mammalian host cells in vitro compared to parasites treated with medium alone. Greater infectivity was also induced by pure human Fc, suggesting a role for Fc receptors on the organism. This inference received support in the fact that protein A inhibited the stimulatory effect of Fc. In addition, Fc-treated parasites incubated with fluorescein-labelled F(ab')2 from goat anti-human IgG exhibited fluorescence detectable by both ultraviolet microscopy and flow cytometry. 125I-Fc binding to T. cruzi was found to be saturable at 0 degrees and was inhibited by cold Fc but not by bovine serum albumin (BSA) or orosomucoid. Interestingly, 125I-Fc binding was greater at 37 degrees and it was not saturable with the concentrations that did saturate at 0 degrees. Possibly, Fc might up-regulate expression of its own receptor and greater endocytosis could take place at 37 degrees. Significant increases in infectivity were detectable after a 40 min pretreatment with Fc--hinting that Fc could trigger a chain of biochemical events underlying the phenomenon--and were reversible, becoming undetectable 2 hr after Fc removal. The average number of Fc receptors per parasite, determined at 0 degrees (at which binding saturation was possible), was estimated as 5 x 10(5), the dissociation constant was of the order of 10(-6)-10(7)M. The present results define an important biological role for an Fc-binding T. cruzi surface component and expose the capacity of this organism to exploit even elements of the immune system in its quest to attain intracellular localization, required for multiplication.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1900054      PMCID: PMC1384346     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  23 in total

1.  Effects of antiserum to Trypanosoma cruzi on the uptake and rate of killing of vector-borne, metacyclic forms of the parasite by macrophages.

Authors:  F Kierszenbaum; M F Lima; J J Wirth
Journal:  Int J Parasitol       Date:  1985-08       Impact factor: 3.981

2.  Cloning and expression of a trypomastigote-specific 85-kilodalton surface antigen gene from Trypanosoma cruzi.

Authors:  G B Takle; A Young; D Snary; L Hudson; S C Nicholls
Journal:  Mol Biochem Parasitol       Date:  1989-11       Impact factor: 1.759

3.  Mechanisms of resistance against experimental Trypanosoma cruzi infection: the importance of antibodies and antibody-forming capacity in the Biozzi high and low responder mice.

Authors:  F Kierszenbaum; J G Howard
Journal:  J Immunol       Date:  1976-05       Impact factor: 5.422

4.  A tubulin-related 55 kilodalton surface antigen recognized by different Trypanosoma cruzi stage-specific monoclonal antibodies from infected mice.

Authors:  A Alcina; M Fresno
Journal:  Mol Biochem Parasitol       Date:  1988-06       Impact factor: 1.759

5.  Purification of a Trypanosoma cruzi membrane glycoprotein which elicits lytic antibodies.

Authors:  K A Norris; G Harth; M So
Journal:  Infect Immun       Date:  1989-08       Impact factor: 3.441

6.  Arginine decarboxylase inhibitors reduce the capacity of Trypanosoma cruzi to infect and multiply in mammalian host cells.

Authors:  F Kierszenbaum; J J Wirth; P P McCann; A Sjoerdsma
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

7.  Trypanosoma cruzi infection in B-cell-deficient rats.

Authors:  A M Rodriguez; F Santoro; D Afchain; H Bazin; A Capron
Journal:  Infect Immun       Date:  1981-02       Impact factor: 3.441

8.  Effects of alpha- and beta-adrenergic agonists on Trypanosoma cruzi interaction with host cells.

Authors:  M C Connelly; A Ayala; F Kierszenbaum
Journal:  J Parasitol       Date:  1988-06       Impact factor: 1.276

9.  Strains and clones of Trypanosoma cruzi differ in their expression of a surface antigen identified by a monoclonal antibody.

Authors:  L V Kirchhoff; J C Engel; J A Dvorak; A Sher
Journal:  Mol Biochem Parasitol       Date:  1984-04       Impact factor: 1.759

10.  Fl-160. A surface antigen of Trypanosoma cruzi that mimics mammalian nervous tissue.

Authors:  W C Van Voorhis; H Eisen
Journal:  J Exp Med       Date:  1989-03-01       Impact factor: 14.307

View more
  5 in total

1.  Binding of a monoclonal antibody to sporozoites of Sarcocystis singaporensis enhances escape from the parasitophorous vacuole, which is necessary for intracellular development.

Authors:  T Jäkel; E Wallstein; F Müncheberg; C Archer-Baumann; B Weingarten; D Kliemt; U Mackenstedt
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

2.  Functional consequences of allotypic polymorphisms in human immunoglobulin G subclasses.

Authors:  Andrew R Crowley; Simone I Richardson; Marina Tuyishime; Madeleine Jennewein; Meredith J Bailey; Jiwon Lee; Galit Alter; Guido Ferrari; Lynn Morris; Margaret E Ackerman
Journal:  Immunogenetics       Date:  2022-07-29       Impact factor: 3.330

3.  An Fc gamma RII-, Fc gamma RIII-specific monoclonal antibody (2.4G2) decreases acute Trypanosoma cruzi infection in mice.

Authors:  T Araujo-Jorge; M T Rivera; A el Bouhdidi; M Daëron; Y Carlier
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

4.  Cloning and characterization of a gene encoding an immunoglobulin-binding receptor on the cell surface of some members of the family Trypanosomatidae.

Authors:  Antonio Campos-Neto; Isabelle Suffia; Karen A Cavassani; Shyian Jen; Kay Greeson; Pamela Ovendale; João S Silva; Steven G Reed; Yasir A W Skeiky
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

Review 5.  Differential regional immune response in Chagas disease.

Authors:  Juliana de Meis; Alexandre Morrot; Désio Aurélio Farias-de-Oliveira; Déa Maria Serra Villa-Verde; Wilson Savino
Journal:  PLoS Negl Trop Dis       Date:  2009-07-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.